Myeloid Antigen Expression in Childhood Acute Lymphoblastic Leukemia and Its Relevance for Clinical Outcome in Indonesian ALL-2006 Protocol

Table 4

Myeloid expression in B-lineage and T-lineage ALL in Yogyakarta, Indonesia.

Variable	B-lineage ALL, 𝑛=183			T-Lineage ALL, 𝑛=56
	𝑛 (%)	My+; 𝑛 (%)	𝑃	𝑛 (%)	My+; 𝑛 (%)	𝑃
Sex
Male	105 (57)	30 (27)	0.66	34 (61)	7 (21)	0.51
Female	78 (43)	20 (26)		22 (39)	3 (14)
Age
1–9 years	145 (80)	41 (28)	0.57	43 (79)	8 (19)	0.79
<1 & 10–14 yrs	38 (20)	9 (24)		13 (21)	2 (15)
White blood cell count
<50.000/mm^3	149 (81)	41 (28)	0.90	36 (64)	6 (17)	0.76
>50.000/mm^3	34 (19)	9 (27)		20 (36)	4 (20)
French-American-British classification
ALL-L1	149 (82)	37 (25)	0.11	49 (88)	7 (14)	0.07
ALL-L2	34 (18)	13 (38)		7 (12)	3 (43)
Risk classification (NCI based)
Standard risk	95 (52)	29 (31)	0.31	0	0	—
High risk	88 (48)	21 (24)		56 (100)	10 (18)